ISPC - iSpecimen to Participate in the Aegis Virtual Conference on February 24 2022
LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”) , an online marketplace for human biospecimens , today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022.
Dr. Ianelli will present on Thursday, February 24, 2022 at 12:30 p.m. ET. To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar .
For more information about the Aegis conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your appropriate Aegis representative directly, or send an email to KCSA Strategic Communications at iSpecimen@kcsa.com .
About iSpecimen
iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. For more information about iSpecimen, please visit www.ispecimen.com .
For further information, please contact:
Investor Contact
KCSA Strategic Communications
Allison Soss
iSpecimen@kcsa.com
Media Contact
KCSA Strategic Communications
Raquel Cona
iSpecimen@kcsa.com